Ingenuity Systems Broadens Use Of Their Products To Japanese Market With License Agreement To Astellas Pharma Inc.

Ingenuity’s product platform selected for usability and content quality after an extensive review of competing products.

REDWOOD CITY, CA – DEC. 5, 2006 - Ingenuity Systems announced a global licensing deal to provide Astellas Pharma Inc. with its IPA software and comprehensive database, the Ingenuity Pathways Knowledge Base. After an extensive review of software products, IPA was chosen for its positive impact on research objectives and its breadth and depth of content.

“Ingenuity Systems is fortifying its presence as a leader and global provider of software for biological exploration, interpretation and analysis in Japan’s growing pharmaceutical market,” commented Ken Taming, President of Tomy Digital Biology, software distributor for Ingenuity Systems. “IPA has increasingly become a standardized tool used for drug discovery and development by many Japanese pharmaceutical companies.”

“We are pleased to add Astellas to our portfolio of clients,” said Jake Leschly, President and CEO of Ingenuity Systems. “Our software will be used broadly by research scientists across their organization and we are thrilled that our database will aid in the success of their systems biology programs.”

IPA is a software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is deployed in all major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally. It supports analysis of all high throughput analysis platforms and is used in virtually all areas of drug discovery and development from target identification and validation to biomarkers, predictive toxicology, and pharmacogenomics.

The Ingenuity Pathways Knowledge Base is a database of biological interactions and functional annotations created from millions of individually modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases. The Ingenuity Pathways Knowledge Base is the largest database of its kind with the most descriptive structure, highest degree of accuracy, and largest number of literature findings.

IPA is available as a web-delivered, hosted, or deployed solution. Fully functional complimentary trials are available at

About Ingenuity Systems®

Ingenuity enables researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan.